Redeye lowers its short-term expectations on Strax due to the corona-crisis. Our long-term view of the case remains optimistic, with an experienced team managing the business and a vast distribution network providing a competitive edge. On the back of a solid Q4'19-report and a share price decline of 50% during March, we identify an attractive opportunity for the long-term investor.

Read more and download the research update: https://bit.ly/2Jl3MBf

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

https://news.cision.com/strax-ab/r/redeye--strax--low-market-expectations,c3072733

(c) 2020 Cision. All rights reserved., source Press Releases - English